This is a dummy test for home page
(Reuters) – No. 2 U.S. nursing home chain HCR ManorCare Inc heads to court on Friday to seek approval for a plan to exit a $7.1 billion Chapter 11 bankruptcy under the ownership of the real estate investment trust whose steep rents lent to its financial demise.
Source: Reuters Medical News
(Reuters Health) – Middle-aged men who are sedentary much of the day and don’t get a lot of exercise are more likely to develop bladder and urinary tract symptoms than their peers who sit less, a Korean study suggests.
Source: Reuters Medical News
(Reuters Health) – People who eat lots of processed and red meat are at increased risk of developing chronic liver disease and insulin resistance, a diabetes risk factor – especially if they like their steak well done, an Israeli study suggests.
Source: Reuters Medical News
(Reuters Health) – Without some kind of health insurance, getting an appointment with a primary care doctor, and being able to pay in full or over time remains a challenge for millions in the U.S., a recent study suggests.
Source: Reuters Medical News
(Reuters Health) – The cost of new anti-cancer drugs increased more than five-fold from 2006 to 2015, but a new analysis suggests that cancer patients and insurers may be getting less for their money.
Source: Reuters Medical News
(Reuters Health) – Pets that visit nursing homes or live there with a resident can be a benefit to all, but administrators also need to consider possible risks like injuries and illness and develop policies to avoid them, researchers say.
Source: Reuters Medical News
JALORE, India (Reuters) – Bhawri Devi, an illiterate Indian laborer, thought she was dying when she started to lose her hearing last month.
Source: Reuters Medical News
BOURNEMOUTH, England (Reuters) – Among Ron Grantham’s happiest memories are the days he spent fly-fishing with his beloved dog, Spot. Now those memories are being revived by visits from his new best friend, Biscuit – a robotic dog.
Source: Reuters Medical News
LONDON (Reuters) – GlaxoSmithKline is divesting its rare disease gene therapy drugs to private biotech company Orchard Therapeutics as Chief Executive Emma Walmsley makes good on her promise to prune the drugmaker’s pharmaceuticals portfolio.
Source: Reuters Medical News
LONDON (Reuters) – Britain’s Orchard Therapeutics, which has already raised more than $140 million to fund its work in gene therapy, plans another private sale of shares following its acquisition of a portfolio of GlaxoSmithKline rare disease medicines.
Source: Reuters Medical News